Cargando…
Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range?
The number of clinical trials using mesenchymal stem cells (MSCs) has increased since 2008, but this trend slowed in the past several years and dropped precipitously in 2018. Previous reports have analyzed MSC clinical trials by disease, phase, cell source, country of origin, and trial initiation da...
Autores principales: | Kabat, Maciej, Bobkov, Ivan, Kumar, Suneel, Grumet, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954709/ https://www.ncbi.nlm.nih.gov/pubmed/31804767 http://dx.doi.org/10.1002/sctm.19-0202 |
Ejemplares similares
-
Anti-Inflammatory Effects of Encapsulated Human Mesenchymal Stromal/Stem Cells and a Method to Scale-Up Cell Encapsulation
por: Kumar, Suneel, et al.
Publicado: (2022) -
Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients
por: Erasmus, David Brett, et al.
Publicado: (2022) -
Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose‐Escalation Clinical Trial
por: Ahn, So Yoon, et al.
Publicado: (2018) -
Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study
por: Grumet, Martin, et al.
Publicado: (2022) -
Language experience during the sensitive period narrows infants’ sensory encoding of lexical tones—Music intervention reverses it
por: Zhao, Tian Christina, et al.
Publicado: (2022)